CAS No. |
108050-54-0 |
英文名称 |
(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-(((2R,3R,4S,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7-(2-((3R,5S)-3,5-dimethylpiperidin-1-yl)ethyl)-16-ethyl-4-hydroxy-15-((((2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)-5,9,13-trimethyloxacyclohexadeca-11,13-diene-2,10-dione |
别名 |
4'-O-De(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-20-deoxo-20-(3,5-dimethyl-1-piperidinyl)tyrosine [antibiotic];Tilmicosin,20-Deoxo-20-(3,5-dimethyl-1-piperidinyl)desmycosin;Tilmicosin (250 mg);Herba Dianthi Superbi;(11Z,13Z)-6-{[4-(diMethylaMino)-3,5-dihydroxy-6-Methyloxan-2-yl]oxy}-7-[2-(3,5-diMethylpiperidin-1-yl)ethyl]-16-ethyl-4-hydroxy-15-{[(5-hydroxy-3,4-diMethoxy-6-Methyloxan-2-yl)oxy]Methyl}-5,9,13-triMethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione;20-Deoxy-20-(3,5-diMethylpiperidin-1-yl)-desMycosin, EL-870;Tylosin, 4A-O-de(2,6-dideoxy-3-C-methyl-α-L-ribo-hexopyranosyl)-20-deoxo-20-[(3R,5S)-3,5-dimethyl-1-piperidinyl]-;20%Tilmicosin |
标准英文名 |
(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-(((2R,3R,4S,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7-(2-((3R,5S)-3,5-dimethylpiperidin-1-yl)ethyl)-16-ethyl-4-hydroxy-15-((((2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)-5,9,13-trimethyloxacyclohexadeca-11,13-diene-2,10-dione |
分子式 |
C46H80N2O13 |
分子量 |
869.15
|
精确分子量 |
868.57
|
SMILES |
CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CCN2C[C@H](C)C[C@H](C)C2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC |
标准SMILES |
CN(C)[C@@H]1[C@@H](O)[C@@H](O[C@H](C)[C@H]1O)O[C@H]1[C@H](C[C@@H](C)C(=O)C=CC(C)=C[C@H](CO[C@@H]2O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]2OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@@H]1C)CCN1C[C@H](C)C[C@H](C)C1 |
用途 |
Tilmicosin is a semi-synthetic macrolide antibiotic derived from a hydrolysis product of tylosin, specifically developed for veterinary use. It is primarily used for the treatment and control of infections in livestock and poultry caused by *Actinobacillus pleuropneumoniae*, *Pasteurella* spp., and *Mycoplasma* spp. It is especially effective against respiratory diseases in animals, such as porcine pleuropneumonia, pasteurellosis, avian mycoplasmosis, and mastitis in lactating animals. Due to its favorable pharmacokinetic properties—including rapid absorption, extensive tissue distribution, high lung and milk concentrations, and prolonged elimination half-life in milk—it is widely used in cattle, goats, sheep, dairy cows, pigs, and chickens. Tilmicosin exhibits broad-spectrum antimicrobial activity against Gram-positive bacteria, certain Gram-negative bacteria, mycoplasmas, and spirochetes, with enhanced efficacy compared to tylosin against *Pasteurella multocida*, *Mannheimia haemolytica*, and *Actinobacillus pleuropneumoniae*. |
InChIKey |
JTSDBFGMPLKDCD-XVFHVFLVSA-N |